Hepatitis C Virus (HCV) Treatment Completion or Withdrawal

Completed

• Conditions: Hepatitis C

• Registration Number: NCT00674492
• Lead Sponsor: US Department of Veterans Affairs

Brief Summary

Qualitative pilot study of patients' views of their experience with antiviral treatment for hepatitis C.

Detailed Description

Qualitative pilot study of patient' views of their experiences with antiviral treatment for hepatitis C. Two groups of patients will be sampled: nine who completed a 24 or 48 week course of treatment and nine who withdrew from treatment prior to planned end. Interview data will be analyzed using narrative and grounded theory methods to identify attributes of treatment experience that may discriminate between completion and withdrawal.

Study Timeline

• Study Start: 2008-05
• Study First Submitted: 2008-05-06
• Study First Submitted QC: 2008-05-07
• Study First Posted: 2008-05-08
• Primary Completion: 2008-08
• Study Completion: 2008-08
• Results First Submitted: 2015-02-05
• Results First Submitted QC: 2015-02-20
• Results First Posted: 2015-03-09
• Status Verified: 2015-04
• Last Update Submitted: 2015-04-27
• Last Update Posted: 2015-05-15

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 21

Inclusion Criteria

Ever initiated anitiviral treatment for hepatitis C.

Exclusion Criteria

none

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Attributes of Treatment Experience	Zero to five years since ending treatment.	Four basic reasons for persisting in antiviral treatment were identified: cure the disease, concern about diminishing time to act (avoid bad end), demonstation of personal strength, and redemption for past behavior.

Trial Locations

Locations (1)

Edith Nourse Rogers Memorial Veterans Hospital, Bedford, MA; 🇺🇸 Bedford, Massachusetts, United States